Where I see patients (6)
Selected research
-
Multi-trait Analysis of GWAS for circulating FGF23 Identifies Novel Network Interactions Between HRG-HMGB1 and Cardiac Disease in CKD.
medRxiv : the preprint server for health sciences
-
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.
JBMR plus
-
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level.
The Journal of clinical endocrinology and metabolism
Clinical trials
Ferric Citrate and Chronic Kidney Disease in Children
Change in iFGF23 levels
Recruiting
More about this studyContact me
Learning never stops